TY - JOUR
T1 - Evaluation of high-throughput genomic assays for the Fc gamma receptor locus
AU - Hargreaves, Chantal E.
AU - Iriyama, Chisako
AU - Rose-Zerilli, Matthew J.J.
AU - Nagelkerke, Sietse Q.
AU - Hussain, Khiyam
AU - Ganderton, Rosalind
AU - Lee, Charlotte
AU - Machado, Lee R.
AU - Hollox, Edward J.
AU - Parker, Helen
AU - Latham, Kate V.
AU - Kuijpers, Taco W.
AU - Potter, Kathleen N.
AU - Coupland, Sarah E.
AU - Davies, Andrew
AU - Stackpole, Michael
AU - Oates, Melanie
AU - Pettitt, Andrew R.
AU - Glennie, Martin J.
AU - Cragg, Mark S.
AU - Strefford, Jonathan C.
N1 - Publisher Copyright:
© 2015 Hargreaves et al.This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 2015/11/6
Y1 - 2015/11/6
N2 - Cancer immunotherapy has been revolutionised by the use monoclonal antibodies (mAb) that function through their interaction with Fc gamma receptors (FcγRs). The low-affinity FcγR genes are highly homologous, map to a complex locus at 1p23 and harbour single nucleotide polymorphisms (SNPs) and copy number variation (CNV) that can impact on receptor function and response to therapeutic mAbs. This complexity can hinder accurate characterisation of the locus. We therefore evaluated and optimised a suite of assays for the genomic analysis of the FcγR locus amenable to peripheral blood mononuclear cells and formalin-fixed paraffin-embedded (FFPE) material that can be employed in a highthroughput manner. Assessment of TaqMan genotyping for FCGR2A-131H/R, FCGR3A-158F/V and FCGR2B-232I/T SNPs demonstrated the need for additional methods to discriminate genotypes for the FCGR3A-158F/V and FCGR2B-232I/T SNPs due to sequence homology and CNV in the region. A multiplex ligation-dependent probe amplification assay provided high quality SNP and CNV data in PBMC cases, but there was greater data variability in FFPE material in a manner that was predicted by the BIOMED-2 multiplex PCR protocol. In conclusion, we have evaluated a suite of assays for the genomic analysis of the FcγR locus that are scalable for application in large clinical trials of mAb therapy. These assays will ultimately help establish the importance of FcγR genetics in predicting response to antibody therapeutics.
AB - Cancer immunotherapy has been revolutionised by the use monoclonal antibodies (mAb) that function through their interaction with Fc gamma receptors (FcγRs). The low-affinity FcγR genes are highly homologous, map to a complex locus at 1p23 and harbour single nucleotide polymorphisms (SNPs) and copy number variation (CNV) that can impact on receptor function and response to therapeutic mAbs. This complexity can hinder accurate characterisation of the locus. We therefore evaluated and optimised a suite of assays for the genomic analysis of the FcγR locus amenable to peripheral blood mononuclear cells and formalin-fixed paraffin-embedded (FFPE) material that can be employed in a highthroughput manner. Assessment of TaqMan genotyping for FCGR2A-131H/R, FCGR3A-158F/V and FCGR2B-232I/T SNPs demonstrated the need for additional methods to discriminate genotypes for the FCGR3A-158F/V and FCGR2B-232I/T SNPs due to sequence homology and CNV in the region. A multiplex ligation-dependent probe amplification assay provided high quality SNP and CNV data in PBMC cases, but there was greater data variability in FFPE material in a manner that was predicted by the BIOMED-2 multiplex PCR protocol. In conclusion, we have evaluated a suite of assays for the genomic analysis of the FcγR locus that are scalable for application in large clinical trials of mAb therapy. These assays will ultimately help establish the importance of FcγR genetics in predicting response to antibody therapeutics.
UR - http://www.scopus.com/inward/record.url?scp=84952685380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952685380&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0142379
DO - 10.1371/journal.pone.0142379
M3 - Article
C2 - 26545243
AN - SCOPUS:84952685380
VL - 10
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 11
M1 - e0142379
ER -